Patents for C40B 30 - Methods of screening libraries (11,320) |
---|
10/11/2012 | US20120258880 Methods and/or Use of Oligonucleotide Conjugates for Assays and Flow Cytometry Detections |
10/11/2012 | US20120258879 Polymorphism Detection |
10/11/2012 | US20120258878 Prognostic gene signatures for non-small cell lung cancer |
10/11/2012 | US20120258877 Identification of cancer biomarkers and phosphorylated proteins |
10/11/2012 | US20120258876 Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology |
10/11/2012 | US20120258875 Methods and apparatus for characterizing polymeric mixtures |
10/11/2012 | US20120258874 Interrogatory cell-based assays and uses thereof |
10/11/2012 | US20120258873 Reduction of 2,3-dihydroxy-2-methyl butyrate (dhmb) in butanol production |
10/11/2012 | US20120258183 Macronutrient sensitivity |
10/11/2012 | US20120258128 Infection Factor Assay |
10/11/2012 | US20120258125 Method to identify a novel class of immunologic adjuvants |
10/11/2012 | US20120258093 Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy |
10/11/2012 | US20120258074 Systems, Models and Methods for Identifying and Evaluating Skin-Active Agents Effective for Treating Dandruff/Seborrheic Dermatitis |
10/11/2012 | US20120258069 Rgd-binding compounds and methods of use |
10/11/2012 | US20120258056 Treatment of cancer and compositions |
10/11/2012 | DE10332848B4 Mikroarrays immobilisierter Biomoleküle, deren Herstellung und Verwendung Microarrays of immobilized biomolecules, their preparation and use |
10/11/2012 | DE102011106984B3 Microarray-Vorrichtung für das Screenen oder Auffinden von HSP90 Inhibitoren und von Inhibitoren weiterer krankheitsrelevanter Zielstrukturen Microarray device for screening or detection of HSP90 inhibitors and inhibitors of other disease-relevant targets |
10/11/2012 | CA2832480A1 High-throughput screening for compounds modulating expression of cellular macromolecules |
10/10/2012 | EP2507733A1 Combined on-lattice/off-lattice optimization method for rigid body docking |
10/10/2012 | EP2507419A1 Methods of modulating thrombocytopenia and modified transgenic pigs |
10/04/2012 | WO2012134602A2 Methods and systems for sequencing long nucleic acids |
10/04/2012 | US20120255044 Urate transporter, as well as method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug |
10/04/2012 | US20120252878 Use of cathepsin h |
10/04/2012 | US20120252867 Method of therapy and diagnosis of atherosclerosis |
10/04/2012 | US20120252856 Pi3k/akt pathway subgroups in cancer: methods of using biomarkers for diagnosis and therapy |
10/04/2012 | US20120252737 Methods for Diagnosing and Treating Cancer |
10/04/2012 | US20120252698 Isolated australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development |
10/04/2012 | US20120252697 Transformed human pluripotent stem cells and associated methods |
10/04/2012 | US20120252696 Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
10/04/2012 | US20120252695 Predictive Value of IL28B Gene Polymorphism Combined with Pretreatment Serum IP-10 Quantification for Response to Peginterferon and Ribavirin Is Enhanced in Comparison with any of these Biomarkers alone |
10/04/2012 | US20120252694 Markers, methods, biochips and kits for milk quality detection |
10/04/2012 | US20120252693 Methods of using small rna from bodily fluids for diagnosis and monitoring of neurodegenerative diseases |
10/04/2012 | US20120252692 Methods and compositions for detection of nucleic acids based on stabilized oligonucleotide probe complexes |
10/04/2012 | US20120252691 Modified nucleotides methods and kits |
10/04/2012 | US20120252690 Method for detecting balanced chromosomal aberrations in a genome |
10/04/2012 | US20120252689 Gene expression signature for wnt/b-catenin signaling pathway and use thereof |
10/04/2012 | US20120252688 Novel biomarkers of disease histopathology |
10/04/2012 | US20120252687 Scoring Function Penalizing Compounds Which Desolvate Charged Protein Side Chains Structure |
10/04/2012 | US20120252686 Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction |
10/04/2012 | US20120252685 Sequential analysis of biological samples |
10/04/2012 | US20120252684 Methods of populating data structures for use in evolutionary simulations |
10/04/2012 | US20120252683 Binding Affinity Scoring Function Penalizing Compounds Which Make Unfavorable Hydrophobic Contacts With Localized Water Molecules In The Receptor Active Site |
10/04/2012 | US20120252682 Methods and systems for sequencing nucleic acids |
10/04/2012 | US20120251619 MicroRNA-29a,b,c as a Tumor Suppressor and Sensitizing Agent for Chemotherapy |
10/04/2012 | US20120251553 Biomarkers for schizophrenia or other psychotic disorders |
10/04/2012 | US20120251524 Use of cytokine levels in intravenous immunoglobulin treatment of alzheimer's disease |
10/04/2012 | US20120251505 HUMAN LYMPHOID TISSUE INDUCER (LTi) CELL COMPOSITIONS AND METHODS OF USE |
10/04/2012 | US20120251451 Renal Cell Carcinoma Biomarkers |
10/04/2012 | CA2831454A1 Modulators of plexin b2 activity |
10/04/2012 | CA2831074A1 Gene expression predictors of cancer prognosis |
10/04/2012 | CA2830365A1 Role of ifng methylation in inflammatory bowel disease |
10/04/2012 | CA2830362A1 Methods of diagnosing and treating intestinal granulomas and low bone density in inflammatory bowel disease |
10/04/2012 | CA2830351A1 Methods of diagnosing ulcerative colitis and crohn's disease |
10/04/2012 | CA2829804A1 Enriched populations of cardiomyocyte lineage cells from pluripotent stem cells |
10/03/2012 | CN102713620A Analyte quantification multiplex microarrays combining internal and external calibration |
10/02/2012 | US8278034 Methods of making frozen tissue microarrays |
10/02/2012 | CA2512332C Process and assembly for simultaneously evaluating a plurality of catalysts |
09/27/2012 | WO2012129457A2 Diagnostic and treatment methods using a ligand library |
09/27/2012 | WO2012129423A2 Biomarker discovery in complex biological fluid using bead or particle based libraries and diagnostic kits and therapeutics |
09/27/2012 | US20120246760 Triterpene oxidase derived from plant belonging to genus glycyrrhiza, gene encoding the same, and method of using the same |
09/27/2012 | US20120245235 Classification of cancers |
09/27/2012 | US20120245166 Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such |
09/27/2012 | US20120245092 Polypeptides having modulatory effects on cells |
09/27/2012 | US20120245089 Use of the sparc microenvironment signature in the treatment of cancer |
09/27/2012 | US20120245054 High-Throughput Assay for Sugar-Mediated Drug Transport |
09/27/2012 | US20120245053 GENE EXPRESSION ANALYSIS METHOD USING TWO DIMENSIONAL cDNA LIBRARY |
09/27/2012 | US20120245052 System and method for analyzing dna mixtures |
09/27/2012 | US20120245051 Objective, quantitative method to predict histological subtype in non-small cell lung cancer |
09/27/2012 | US20120245050 Biomarker for predicting therapeutic efficacy of allergen immunotherapy |
09/27/2012 | US20120245049 System and Method for Pixelated Fluid Assay |
09/27/2012 | US20120245048 Cellular response assay for biofluid biomarker discovery and detection |
09/27/2012 | US20120245047 Device and methods for molecular analysis |
09/27/2012 | US20120245046 Gene expression profiling from ffpe samples |
09/27/2012 | US20120245045 Methods and kits to identify invasive glioblastoma |
09/27/2012 | US20120245044 Methods of determining chemotherapy response in cancer |
09/27/2012 | US20120245043 Systems and methods for detecting and identifying contaminants in a gaseous environment |
09/27/2012 | US20120245042 Debubbler for microfluidic systems |
09/27/2012 | US20120244164 Biological materials related to c-met |
09/27/2012 | US20120244160 Identification of modulators of serine protease inhibitor kazal and their use as anti-cancer and anti-viral agents |
09/27/2012 | US20120244131 Method for modulating the efficiency of double-strand break-induced mutagenesis |
09/27/2012 | US20120244067 Methods for inducing reversible stasis |
09/27/2012 | CA2830613A1 Assay for screening compounds that selectively decrease the number of cancer stem cells |
09/27/2012 | CA2830562A1 Mucin 5b as a pancreatic cyst fluid specific biomarker for accurate diagnosis of mucinous cysts and other markers useful for detection of pancreatic malignancy |
09/27/2012 | CA2830443A1 Multiplexed digital assays with combinatorial use of signals |
09/26/2012 | EP2501714A1 Heteropeptides useful for reducing nonspecific adsorption |
09/25/2012 | US8273778 Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth |
09/20/2012 | WO2012122657A1 Nlrp7-based diagnosis of female reproductive conditions |
09/20/2012 | WO2012122626A1 Prognostic marker sets for prostate cancer |
09/20/2012 | US20120240247 Jnk3 modulators and methods of use |
09/20/2012 | US20120238472 Bioanalytical instrumentation using a light source subsystem |
09/20/2012 | US20120238471 Ultrasensitive Biochemical Sensing Device and Method of Sensing Analytes |
09/20/2012 | US20120238470 Method for screening and quantifying various enzyme activities using a genetic enzyme screening system |
09/20/2012 | US20120238469 Diagnostic biomarker to identify women at risk for preterm delivery |
09/20/2012 | US20120238468 Methods for diagnosing irritable bowel syndrome |
09/20/2012 | US20120238467 Exosome-associated microrna as a diagnostic marker |
09/20/2012 | US20120238466 Multiplexed Assay Using Encoded Solid Support Matrices |
09/20/2012 | US20120238465 Drug screening target for alzheimer's disease and method of screening potential drugs |
09/20/2012 | US20120238464 Biomarkers for Predicting the Recurrence of Colorectal Cancer Metastasis |
09/20/2012 | US20120238463 LINE-1 Hypomethylation as a Biomarker for Early-Onset Colorectal Cancer |
09/20/2012 | US20120238462 Methods for regulating the growth and/or survival of tumor cells and stem cells by modulating the expression or function of the transcription factors atf5 |